FINCH THERAPEUTICS GROUP INC (FNCH) Forecast, Price Target & Analyst Ratings

NASDAQ:FNCH • US31773D2009

Current stock price

1.8 USD
-0.18 (-9.09%)
At close:
1.8001 USD
+0 (+0.01%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FINCH THERAPEUTICS GROUP INC (FNCH).

Forecast Snapshot

Consensus Price Target

Price Target
$91.80
+ 5,000.00% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$91.80
Upside
+ 5,000.00%
From current price of $1.80 to mean target of $91.80, Based on 7 analyst forecasts
Low
$90.90
Median
$91.80
High
$94.50

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for FNCH. The average price target is 91.8 USD. This implies a price increase of 5000% is expected in the next year compared to the current price of 1.8.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

FNCH Current Analyst RatingFNCH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

FNCH Historical Analyst RatingsFNCH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
FNCH was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about FNCH.
In the previous month the buy percentage consensus was at a similar level.
FNCH was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-05-12HC Wainwright & Co.Reiterate Buy -> Buy
2022-08-09HC Wainwright & Co.Initiate Buy
2021-04-13Evercore ISI GroupInitiate Outperform
2021-04-13B of A SecuritiesInitiate Buy
2021-04-13JefferiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
FNCH revenue by date.FNCH revenue by date.
18.53M
140.03%		860K
-95.36%		107K
-87.56%
-100.00%		90.27M352.31M
290.28%		699.31M
98.49%		843.95M
20.68%		959.82M
13.73%		1.099B
14.50%
EBITDA
YoY % growth
FNCH ebitda by date.FNCH ebitda by date.
-57.69M
-49.26%		-89.61M
-55.33%		-32.482M
63.75%		-52.326M
-61.09%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
FNCH ebit by date.FNCH ebit by date.
-59.99M
-52.10%		-95.12M
-58.56%		-34.002M
64.25%		-33.66M
1.01%		N/AN/AN/AN/AN/AN/A
Operating Margin
FNCH operating margin by date.FNCH operating margin by date.
-323.75%-11,060.47%-31,777.57%N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
FNCH eps by date.FNCH eps by date.
-13.53N/A
-360.24%		N/A
37.59%		-21.00
45.96%		N/AN/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

FNCH Yearly Revenue VS EstimatesFNCH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
FNCH Yearly EPS VS EstimatesFNCH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -20 -40 -60

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
1,411.62%
Revenue Next 5 Year
507.50%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

FINCH THERAPEUTICS GROUP INC / FNCH Forecast FAQ

Can you provide the average price target for FINCH THERAPEUTICS GROUP INC stock?

7 analysts have analysed FNCH and the average price target is 91.8 USD. This implies a price increase of 5000% is expected in the next year compared to the current price of 1.8.

What is the expected long term growth rate for FNCH stock?

The expected long term growth rate for FINCH THERAPEUTICS GROUP INC (FNCH) is 1411.62%.